In chronic immune and inflammatory diseases, a characteristic feature is the continued recruitment and accumulation in tissues of mononuclear leukocytes (lymphocytes and monocytes). Much evidence points to dysfunction and/or activation of endothelium as a critical factor underlying this process. Inflammatory cytokines and bacterial products induce localized endothelial cell activation and initiate endothelial-dependent mechanisms that mediate leukocyte firm adhesion and transmigration. Although much attention has been paid to leukocyte-endothelial adhesive interactions, only recently have the molecular mechanisms for leukocyte passage through the endothelial lateral junctions become a focus of study. Our laboratory and others have shown that leukocyte adhesion alters adherens junctions (e.g., VE-cadherin complex) at endothelial lateral borders, during the transmigration event (1-3). Junction Adhesion Molecule (JAM) is a recently identified molecule concentrated at cell-cell borders of murine endothelium and epithelium, and participates in monocyte transmigration across endothelial cells in vivo and in vitro (4). Preliminary studies presented in this application have identified the putative human JAM molecule. The overall goals of this application are to characterize the newly discovered human JAM adhesion pathway in the context of mononuclear leukocyte recruitment and function in endothelial cell lateral junctions.
Specific Aim 1 will determine the expression of human JAM in resting and cytokine activated endothelium and the exact role in the leukocyte-endothelial adhesion cascade using live time videomicroscopy in an in vitro flow model. The experiments proposed in Specific 2 will determine the role of JAM in endothelial cell-to-cell adhesion (independent of leukocyte adhesion/transmigration) and association with other proteins localized to cell junctions or the cytoskeleton.
Specific Aim 3 will utilize in vivo models of chronic inflammation or immune reactions to test the potential role of human JAM in leukocyte recruitment.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
1R01HL065090-01
Application #
6080816
Study Section
Special Emphasis Panel (ZAR1-AAA-B (O2))
Program Officer
Serrate-Sztein, Susana
Project Start
1999-09-30
Project End
2004-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115
Lim, Yaw-Chyn; Luscinskas, Francis W (2006) Isolation and culture of murine heart and lung endothelial cells for in vitro model systems. Methods Mol Biol 341:141-54
Rao, Ravi M; Shaw, Sunil K; Kim, Michael et al. (2005) Emerging topics in the regulation of leukocyte transendothelial migration. Microcirculation 12:83-9
Liu, Yuan; Shaw, Sunil K; Ma, Shuo et al. (2004) Regulation of leukocyte transmigration: cell surface interactions and signaling events. J Immunol 172:7-13
Ehlers, Raila; Ustinov, Valentin; Chen, Zhiping et al. (2003) Targeting platelet-leukocyte interactions: identification of the integrin Mac-1 binding site for the platelet counter receptor glycoprotein Ibalpha. J Exp Med 198:1077-88
Lim, Yaw-Chyn; Garcia-Cardena, Guillermo; Allport, Jennifer R et al. (2003) Heterogeneity of endothelial cells from different organ sites in T-cell subset recruitment. Am J Pathol 162:1591-601
Ancuta, Petronela; Rao, Ravi; Moses, Ashlee et al. (2003) Fractalkine preferentially mediates arrest and migration of CD16+ monocytes. J Exp Med 197:1701-7
Luscinskas, Francis W; Ma, Shuo; Nusrat, Asma et al. (2002) The role of endothelial cell lateral junctions during leukocyte trafficking. Immunol Rev 186:57-67
Allport, Jennifer R; Lim, Yaw-Chyn; Shipley, J Michael et al. (2002) Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J Leukoc Biol 71:821-8
Boyce, Joshua A; Mellor, Elizabeth A; Perkins, Brandy et al. (2002) Human mast cell progenitors use alpha4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions. Blood 99:2890-6
Luscinskas, Francis W; Ma, Shuo; Nusrat, Asma et al. (2002) Leukocyte transendothelial migration: a junctional affair. Semin Immunol 14:105-13

Showing the most recent 10 out of 14 publications